Noninvasive biomarker-based risk stratification for development of new onset atrial fibrillation after coronary artery bypass surgery.

MLA

Rizvi, Farhan, et al. “Noninvasive Biomarker-Based Risk Stratification for Development of New Onset Atrial Fibrillation after Coronary Artery Bypass Surgery.” International Journal of Cardiology, vol. 307, May 2020, pp. 55–62. EBSCOhost, https://doi.org/10.1016/j.ijcard.2019.12.067.

APA

Rizvi, F., Mirza, M., Olet, S., Albrecht, M., Edwards, S., Emelyanova, L., Kress, D., Ross, G. R., Holmuhamedov, E., Tajik, A. J., Khandheria, B. K., & Jahangir, A. (2020). Noninvasive biomarker-based risk stratification for development of new onset atrial fibrillation after coronary artery bypass surgery. International Journal of Cardiology, 307, 55–62. https://doi.org/10.1016/j.ijcard.2019.12.067

Chicago

Rizvi, Farhan, Mahek Mirza, Susan Olet, Melissa Albrecht, Stacie Edwards, Larisa Emelyanova, David Kress, et al. 2020. “Noninvasive Biomarker-Based Risk Stratification for Development of New Onset Atrial Fibrillation after Coronary Artery Bypass Surgery.” International Journal of Cardiology 307 (May): 55–62. doi:10.1016/j.ijcard.2019.12.067.